Pharming (PHAR) Asset Utilization Ratio (2021 - 2026)

Pharming's Asset Utilization Ratio history runs 6 years deep, the most recent figure standing at 0.34 for Q1 2026.

• Quarterly Asset Utilization Ratio rose 6.27% year-over-year to 0.34 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 0.34 (up 6.27% YoY) and the FY2025 annual result came in at 0.84, up 21.34% from the prior year.
• Asset Utilization Ratio was 0.34 for Q1 2026 at Pharming, up from 0.2 in the prior quarter.
• Across five years, Asset Utilization Ratio topped out at 0.83 in Q3 2023 and bottomed at 0.0 in Q2 2025.
• A 5-year average of 0.32 and a median of 0.31 in 2024 frame the typical range for Asset Utilization Ratio.
• Annual changes were most pronounced in 2023 — Asset Utilization Ratio surged 1361670.88% — and 2025, when it sank 100.0%.
• Pharming's Asset Utilization Ratio stood at 0.0 in 2022, then soared by 29030.68% to 0.46 in 2023, then plunged by 31.63% to 0.31 in 2024, then tumbled by 36.39% to 0.2 in 2025, then surged by 71.71% to 0.34 in 2026.
• Business Quant data shows PHAR's Asset Utilization Ratio at 0.34 in Q1 2026, 0.2 in Q4 2025, and 0.21 in Q3 2025.